Skip to content

Eustachian Tube Testing in a Pressure Chamber -- Validation Study

Eustachian Tube Testing in a Pressure Chamber -- Validation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00694486
Enrollment
20
Registered
2008-06-10
Start date
2008-01-31
Completion date
2010-07-31
Last updated
2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otitis

Keywords

otitis, Eustachian tube function, Normal middle ear status

Brief summary

This study will compare Eustachian tube function (ETF) testing in adults with intact tympanic membranes (TM) using a pressure chamber to that obtained using standard methods requiring a non-intact TM.

Detailed description

The investigators propose to introduce new test methods and protocols to our laboratory for better clinical characterization of Eustachian tube function in ears with intact TM's. These test will be done in a pressure-chamber and will use previously published and newly developed methods. Participation will require a minimum of 5 visits to the ENT Research Center, 1 for myringotomy (putting a small hole in the eardrum) and 4 for ETF testing. Hearing testing will be done at entry and exit; otoscopy (looking at the ears) and tympanometry (a test done with an earplug and varying pressures in the ear canal) are done at every visit.

Interventions

None listed

Sponsors

National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \>18 years old * Normal middle-ear status

Exclusion criteria

* Chronic illness including asthma, pulmonary, or cardiac problems * Pregnancy * \>10 dB hearing loss in any of the speech frequencies * Past history of sensitivity or allergic reaction to lidocaine or related compounds

Design outcomes

Primary

MeasureTime frame
Eustachian tube function testing resultsup to 3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026